Sort   by:  
 Page size 
UnknownStaged Screening Identifies People with Biomarkers Related to Neuronal Alpha-Synuclein Disease.
Not available
S-EPMC11889527 | biostudies-literature
UnknownNeuronal α-Synuclein Disease Stage Progression over 5 Years.
Not available
S-EPMC12273616 | biostudies-literature
UnknownThe Impact of the COVID-19 Pandemic on Care Partners of People with Parkinson's Disease.
Not available
S-EPMC10105120 | biostudies-literature
UnknownExposure-Efficacy Meta-Model of Nintedanib in Adult Patients With Chronic Fibrosing Interstitial Lung Diseases.
Not available
S-EPMC12823292 | biostudies-literature
UnknownParametric Time-to-Event Model for Acute Exacerbations in Idiopathic Pulmonary Fibrosis.
Not available
S-EPMC7020291 | biostudies-literature
UnknownPopulation Pharmacokinetics and Exposure-Response Model-Based Bayesian Extrapolation of FVC-Based Efficacy Endpoints From Adults to Pediatric Patients Receiving Nintedanib.
Not available
S-EPMC12823301 | biostudies-literature
UnknownInnovative Recruitment Strategies to Increase Diversity of Participation in Parkinson's Disease Research: The Fox Insight Cohort Experience.
Not available
S-EPMC7242847 | biostudies-literature
UnknownPractical recommendations for fertility preservation in women by the FertiPROTEKT network. Part II: fertility preservation techniques.
Not available
S-EPMC5762782 | biostudies-literature
UnknownComparison of an Online-Only Parkinson's Disease Research Cohort to Cohorts Assessed In Person.
Not available
S-EPMC7242834 | biostudies-literature
UnknownAssessing Drug-Drug Interaction and Food Effect for BCS Class 2 Compound BI 730357 (Retinoic Acid-Related Orphan Receptor Gamma Antagonist, Bevurogant) Using a Physiology-Based Pharmacokinetics Modeling (PBPK) Approach with Semi-Mechanistic Absorption.
Not available
S-EPMC11945243 | biostudies-literature
Sort   by:  
 Page size